Suppr超能文献

使用锌指核酸酶(ZFN)mRNA和腺相关病毒6型(AAV6)供体在造血干细胞和祖细胞中进行同源性驱动的基因组编辑。

Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.

作者信息

Wang Jianbin, Exline Colin M, DeClercq Joshua J, Llewellyn G Nicholas, Hayward Samuel B, Li Patrick Wai-Lun, Shivak David A, Surosky Richard T, Gregory Philip D, Holmes Michael C, Cannon Paula M

机构信息

Sangamo BioSciences, Inc., Richmond, California, USA.

Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

出版信息

Nat Biotechnol. 2015 Dec;33(12):1256-1263. doi: 10.1038/nbt.3408. Epub 2015 Nov 9.

Abstract

Genome editing with targeted nucleases and DNA donor templates homologous to the break site has proven challenging in human hematopoietic stem and progenitor cells (HSPCs), and particularly in the most primitive, long-term repopulating cell population. Here we report that combining electroporation of zinc finger nuclease (ZFN) mRNA with donor template delivery by adeno-associated virus (AAV) serotype 6 vectors directs efficient genome editing in HSPCs, achieving site-specific insertion of a GFP cassette at the CCR5 and AAVS1 loci in mobilized peripheral blood CD34 HSPCs at mean frequencies of 17% and 26%, respectively, and in fetal liver HSPCs at 19% and 43%, respectively. Notably, this approach modified the CD34CD133CD90 cell population, a minor component of CD34 cells that contains long-term repopulating hematopoietic stem cells (HSCs). Genome-edited HSPCs also engrafted in immune-deficient mice long-term, confirming that HSCs are targeted by this approach. Our results provide a strategy for more robust application of genome-editing technologies in HSPCs.

摘要

事实证明,在人类造血干细胞和祖细胞(HSPCs)中,使用与断裂位点同源的靶向核酸酶和DNA供体模板进行基因组编辑具有挑战性,尤其是在最原始的长期再增殖细胞群体中。在此,我们报告称,将锌指核酸酶(ZFN)mRNA的电穿孔与腺相关病毒(AAV)血清型6载体的供体模板递送相结合,可在HSPCs中实现高效的基因组编辑,在动员的外周血CD34 HSPCs中,绿色荧光蛋白(GFP)盒在CCR5和AAVS1位点的位点特异性插入平均频率分别为17%和26%,在胎儿肝脏HSPCs中分别为19%和43%。值得注意的是,这种方法改变了CD34+CD133+CD90+细胞群体,该群体是CD34+细胞中的一个小部分,包含长期再增殖造血干细胞(HSCs)。经基因组编辑的HSPCs也能长期植入免疫缺陷小鼠体内,证实这种方法能够靶向HSCs。我们的研究结果为在HSPCs中更有力地应用基因组编辑技术提供了一种策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7f4/4842001/7a77f01b3f16/nihms731486f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验